PD Dr. Hemmi Silvio
Main Field(s) of Research, Abstract
The overall aim of
our research is the use of adenovirus (Ad) for the treatment of
established tumors through manipulation of the immune system as well as
by the viral cytotoxic means, as an alternatives to conventional
therapies like radiotherapy, chemotherapy and surgery. At the moment we
focus predominantly on melanoma as for this type of cancer several
animal melanoma models exist and as human melanomas can be grown in
nude mice.
The following specific projects are of main interest:
1) Analysis of human melanoma cell cultures for their correlation of
CAR-expression (primary Ad receptor) and efficacy of Ad-mediated
transgene expression. These studies allow predictions on how much virus
is needed to reach a desired therapeutic transgene expression. This
project also involves search for additional receptor targets to improve
infection efficiency, altering e.g. fiber head of the virus to insert
new targeting motifs.
2) Development of attenuated replication competent Ads in order to
exploit the cytopathic effect of Ad replication for melanoma tumor cell
eradication. Such a virus was tested in the nude mouse model and
revealed the selective oncolytic activity of this virus for melanoma
cells. An extension of this project includes the production of a virus
with specificity for cutaneous lymphoma.
Main Fields of Research, Keywords
Adenovirus, virus-targeting, virus-receptors, oncolytic viruses, melanoma, cutaneous lymphoma.
Special Techniques and Equipment
Recombinant adenovirus production.
Education and Training
We have training opportunities for diploma students, PhD students, PostDocs and medical dissertations.

